Bioavailability refers to the rate and extent to which an administered drug reaches systemic circulation and is available at its site of action. Absolute bioavailability is determined by comparing systemic availability after oral administration to intravenous administration, while relative bioavailability compares two different oral administrations. Bioavailability is influenced by factors like first-pass hepatic metabolism, route of administration, and chemical instability in the gastrointestinal tract. It provides an important measure of how much of a drug will have an effect.
Bioavailability refers to the rate and extent to which an administered drug reaches systemic circulation and is available at its site of action. Absolute bioavailability is determined by comparing systemic availability after oral administration to intravenous administration, while relative bioavailability compares two different oral administrations. Bioavailability is influenced by factors like first-pass hepatic metabolism, route of administration, and chemical instability in the gastrointestinal tract. It provides an important measure of how much of a drug will have an effect.
Bioavailability refers to the rate and extent to which an administered drug reaches systemic circulation and is available at its site of action. Absolute bioavailability is determined by comparing systemic availability after oral administration to intravenous administration, while relative bioavailability compares two different oral administrations. Bioavailability is influenced by factors like first-pass hepatic metabolism, route of administration, and chemical instability in the gastrointestinal tract. It provides an important measure of how much of a drug will have an effect.
Bioavailability refers to the rate and extent to which an administered drug reaches systemic circulation and is available at its site of action. Absolute bioavailability is determined by comparing systemic availability after oral administration to intravenous administration, while relative bioavailability compares two different oral administrations. Bioavailability is influenced by factors like first-pass hepatic metabolism, route of administration, and chemical instability in the gastrointestinal tract. It provides an important measure of how much of a drug will have an effect.
and extent of absorption of unchanged drug from its dosage form and become available at the site of action. • Rate and extent at which therapeutically drug reaches systemic circulation. • A measure relative to some standard of rate & amount of drug, which reaches the systemic circulation unchanged following the administration of dosage form. Types of Bioavailability
Relative Bioavailability (Fr): If
Absolute Bioavailability (F): If the systemic availability of a the systemic availability of a drug administered orally is drug administered orally is determined by doing its determined by doing its comparison with that of an oral comparison with I.V. standard of the same drug, it is administration, it is known as known as a relative absolute bioavailability. bioavailability. • Range of Bioavailability – 0 to 1. • It is usually expressed as percentages (%). • An absolute bioavailability of 1 (or 100%) indicates complete absorption. • Relative bioavailability of 1 (or 100%) implies that the bioavailability of drug from both the dosage forms is the same but does not indicate the completeness of the systemic drug absorption. • Drugs having 100% bioavailability. • Drugs having 100% bioavailability include chlordiazepoxide, diazepam, lithium, metronidazole, phenobarbitol, salicylic acid, trimethoprin and valproic acid. Determination of bioavailability • Bioavailability is determined by comparing plasma levels of a drug after a particular route of administration (for example, oral administration) with plasma drug levels achieved by IV injection in which all of the agent rapidly enters the circulation. When the drug is given orally, only part of the administered dose appears in the plasma. • By plotting plasma concentrations of the drug versus time, we can measure the area under the curve (AUC). • This curve reflects the extent of absorption of the drug. [Note: By definition, this is 100 percent for drugs delivered IV]. • Bioavailability of a drug administered orally is the ratio of the area calculated for oral administration compared with the area calculated for IV injection. • Bioavailability (the rate and extent of drug absorption) is generally assessed by the determination of following three parameters. They are : • Cmax (Peak plasma concentration). • tmax(time of peak). • Area under curve. • AUC: Is the measurement of the extent of the drug bioavailability It is the area under the drug plasma level-time curve from t =0 & t = ∞ and is equal to the amount of unchanged drug reaching the general circulation divided by the clearance. • Cmax: (Peak plasma drug concentration) • Maximum concentration of the drug obtained after the administration of single dose of the drug. • Expressed in terms of μg/ml or mg/ml. • tmax: (Time of peak plasma concentration) • Time required to achieve peak concentration of the drug after administration. • Gives indication of the rate of absorption. • Expressed in terms of hours or minutes. Factors That Influence Bioavailability 1.First-pass hepatic metabolism: When a drug is absorbed across the GI tract, it enters the portal circulation before entering the systemic circulation. If the drug is rapidly metabolized by the liver, the amount of unchanged drug that gains access to the systemic circulation is decreased. • Many drugs, such as propranolol or lidocaine, undergo significant biotransformation during a single passage through the liver. 2- Clinical Significance: • Bioavailability differs with the dosage forms. Drug in liquid form have more bioavailability than those of solids, while gases have the highest bioavailability. This is why inhalation is used in bronchial asthma. • With the same brand, dosage form manufactured by different companies may differ in bioavailability. • Three terms are generally used: a.Bioequivalence: Two related drugs are bioequivalent if they show comparable bioavailability and similar times to achieve peak blood concentrations. • Two related drugs with a significant difference in bioavailability are said to be bioinequivalent. • Therapeutic equivalence: Two similar drugs are therapeutically equivalent if they have comparable efficacy and safety. • Clinical effectiveness often depends on both the maximum serum drug concentrations and on the time required (after administration) to reach peak concentration. Therefore, two drugs that are bioequivalent may not be therapeutically equivalent. b.Therapeutic equivalent • If two similar drugs perform the same effect, have same efficacy and toxicity, then they are called therapeutically equivalent. • It indicates that two or more drug products that contain the same therapeutic active ingredients elicit same pharmacologic effects and can control the disease to the same extent. c. Chemical Equivalent • Chemical equivalence: two or more formulations contain the same labelled chemical substance as an active ingredient in the same amount. 3. Route of administration • Drugs given by intravenous route have 100% bioavailability. Exception includes prostaglandins, which are inactivated/metabolized in the lungs, therefore, their bioavailability may be zero after I/V injection. Those given by intramuscular route have bioavailability less than I/V route but more than subcutaneous route, while subcutaneous route has bioavailability more than the oral route. • Only 10% of the dose of digoxin reaches systemic circulation after oral administration because of lack of absorption and bacterial metabolism within intestines. Even some of the drugs given by oral route may have 100% bioavailability but this is rare. • By rectal route, half of the drug undergoes first pass metabolism. • Chloramphenicol, an antibiotic, administered by intravenous route has bioavailability less than oral route because it is present in pro form and has to be activated in the intestines. 4. Chemical Instability • Drug may be destroyed by the HCl or enzymes present in the GIT. Benzyl penicillin is not given orally because it is destroyed by HCl. Parenteral route is generally preferred. Therapeutic Index: • Therapeutic index represents the safety of a drug. Drugs having large therapeutic index and safer and vice versa. THANK YOU